Loading clinical trials...
Loading clinical trials...
A Randomized Controlled Trial Examining Extended-Release Injectable Buprenorphine in Those Who Use High Potency Synthetic Opioids
Conditions
Interventions
Buprenorphine + naloxone (Suboxone)
Buprenorphine Injection
Locations
1
United States
Substance Treatment and Research Service
New York, New York, United States
Start Date
August 1, 2026
Primary Completion Date
January 15, 2029
Completion Date
January 15, 2029
Last Updated
March 4, 2026
NCT04587791
NCT05492825
NCT05942313
NCT06651177
NCT06843213
NCT05995886
Lead Sponsor
Rachel R. Luba
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions